Data / Drug companies / Brimonidine tartrate and timolol maleate
Brimonidine tartrate and timolol maleate: 14 companies and 20 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Brimonidine tartrate and timolol maleate is listed in the FDA National Drug Code Directory by 14 companies, with 20 products in commercial distribution. 20 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution/ drops; solution, and the newest product started marketing on September 15, 2026.
The request: Get every company that lists brimonidine tartrate and timolol maleate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 14
- Products
- 20
- Generic (ANDA) products
- 20 (100.0%)
- Application numbers
- 10
- Routes
- Ophthalmic
- Brand names
- Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, Brimonidine Tartrate/Timolol Maleate
- openFDA record search
- api.fda.gov
Companies that list brimonidine tartrate and timolol maleate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Caplin Steriles Limited | 3 | solution | Generic drugs (ANDA) | March 10, 2025 |
| Gland Pharma Limited | 3 | solution/ drops | Generic drugs (ANDA) | June 11, 2026 |
| Somerset Therapeutics, LLC | 3 | solution/ drops | Generic drugs (ANDA) | October 10, 2024 |
| Alembic Pharmaceuticals Inc. | 1 | solution/ drops | Generic drugs (ANDA) | August 25, 2023 |
| Alembic Pharmaceuticals Limited | 1 | solution/ drops | Generic drugs (ANDA) | August 25, 2023 |
| Apotex Corp. | 1 | solution | Generic drugs (ANDA) | October 19, 2022 |
| Armas Pharmaceuticals Inc. | 1 | solution/ drops | Generic drugs (ANDA) | November 3, 2023 |
| Devatis, Inc. | 1 | solution/ drops | Generic drugs (ANDA) | September 15, 2026 |
| Florida Pharmaceutical Products, LLC | 1 | solution | Generic drugs (ANDA) | November 23, 2023 |
| Glenmark Pharmaceuticals Inc., USA | 1 | solution/ drops | Generic drugs (ANDA) | May 16, 2024 |
| Leading Pharma, LLC | 1 | solution | Generic drugs (ANDA) | May 29, 2025 |
| NorthStar RxLLC | 1 | solution/ drops | Generic drugs (ANDA) | November 23, 2023 |
| Sandoz Inc | 1 | solution/ drops | Generic drugs (ANDA) | April 13, 2022 |
| Upsher-Smith Laboratories, LLC | 1 | solution/ drops | Generic drugs (ANDA) | December 15, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution/ drops | 14 | 70% |
| Solution | 6 | 30% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 20 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| alpha-Adrenergic Agonist | 20 |
| beta-Adrenergic Blocker | 20 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.